You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Aflibercept (Eylea)

Showing 1 - 25 of 432
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chorioretinal Vascular Disease Trial (ABP 938, Aflibercept)

Not yet recruiting
  • Chorioretinal Vascular Disease
  • (no location specified)
Jan 20, 2023

Diabetic Macular Edema (DME), Neovascular Age-Related Macular Degeneration (nAMD) Trial (aflibercept 8 mg PFS)

Not yet recruiting
  • Diabetic Macular Edema (DME)
  • Neovascular Age-Related Macular Degeneration (nAMD)
  • aflibercept 8 mg PFS
  • (no location specified)
Aug 3, 2023

Macular Degeneration (AMD) Post-marketing Surveillance in Japan

Completed
  • Macular Degeneration
  • Aflibercept(Eylea, VEGF Trap-Eye, BAY86-5321)
  • Multiple Locations, Japan
    (unnamed)
Jan 9, 2023

Aflibercept Injection in Japanese Neovascular Glaucoma (NVG)

Recruiting
  • Neovascular Glaucoma
  • Aflibercept (Eylea, BAY86-5321)
  • Multiple Locations, Japan
    Many locations
Aug 17, 2022

Eylea in Babies Born Too Early Who HaveCondition of Eye Where

Not yet recruiting
  • Retinopathy of Prematurity
  • +2 more
  • Aflibercept (Eylea, BAY86-5321)
  • Multiple Locations, Japan
    Many locations
Jan 20, 2023

Data of Intravitreal Aflibercept Injection in Patients of Wet

Completed
  • Wet Age-related Macular Degeneration
  • Aflibercept (Eylea, BAY86-5321)
  • Multiple Locations, India
    Many Locations
Feb 2, 2023

Diabetic Macular Edema Trial in Beijing (9MW0813, Aflibercept)

Recruiting
  • Diabetic Macular Edema
  • Beijing, Beijing, China
    Beijing tongren hospital affliated to capital medical university
Apr 5, 2022

Diabetic Macular Edema Trial in Beijing (9MW0813, Aflibercept)

Completed
  • Diabetic Macular Edema
  • Beijing, Beijing, China
    Beijing tongren hospital affliated to capital medical university
Apr 5, 2022

naïve Age-related Macular Degeneration of Neovascular Type and

Completed
  • Age-related Macular Degeneration
  • Data extraction from medical files
  • Brussels, Belgium
    CHU Brugmann
Mar 7, 2022

g Medical Records to Learn More About Treat-and-extend With

Completed
  • Neovascular Age-related Macular Degeneration
  • Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)
  • Multiple Locations, Belgium
    Many Locations
Jun 9, 2022

Chorioretinal Vascular Disease Trial in Houston, The Woodlands (Intravitreal Aflibercept Injection (IAI))

Completed
Has Results
  • Chorioretinal Vascular Disease
  • Intravitreal Aflibercept Injection (IAI)
  • Houston, Texas
  • +1 more
Aug 18, 2021

Diabetic Macular Edema Trial in Ahmedabad (Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321))

Not yet recruiting
  • Diabetic Macular Edema
  • Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)
  • Ahmedabad, Gujarat, India
    Raghudeep Eye Hospital
Aug 19, 2022

Learn More About How Drug Aflibercept Works in Canadian Reduced

Active, not recruiting
  • Myopic Choroidal Neovascularization
  • Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)
  • Multiple Locations, Canada
    Many Locations
Jul 25, 2022

Age-Related Macular Degeneration, Neovascular Age-related Macular Degeneration Trial in Tehran (Aflibercept (CinnaGen Co, Iran),

Completed
  • Age-Related Macular Degeneration
  • Neovascular Age-related Macular Degeneration
  • Aflibercept (CinnaGen Co, Iran)
  • Aflibercept (Regeneron, USA)
  • Tehran, Iran, Islamic Republic of
    Farabi Hospital
Oct 16, 2022

Metastatic Uveal Melanoma Trial in Tampa (ZIV-Aflibercept, Cemiplimab)

Recruiting
  • Metastatic Uveal Melanoma
  • Tampa, Florida
    Moffitt Cancer Center
Nov 2, 2023

Neovascular Age-related Macular Degeneration Trial in Graz (Aflibercept 40 MG/ML, Faricimab 120 MG/ML)

Recruiting
  • Neovascular Age-related Macular Degeneration
  • Aflibercept 40 MG/ML
  • Faricimab 120 MG/ML
  • Graz, Styria, Austria
    Department of Ophthalmolgy, Medical University Graz
Jul 3, 2023

Polypoidal Choroidal Vasculopathy Trial in Singapore (Aflibercept + reduced fluence photodynamic therapy (RF-PDT), Aflibercept +

Recruiting
  • Polypoidal Choroidal Vasculopathy
  • Aflibercept + reduced fluence photodynamic therapy (RF-PDT)
  • Aflibercept + sham reduced fluence photodynamic therapy (RF-PDT)
  • Singapore, Singapore
  • +2 more
Nov 14, 2022

Wet Age-related Macular Degeneration Trial in Beijing (RC28-E, Aflibercept)

Recruiting
  • Wet Age-related Macular Degeneration
  • Beijing, Beijing, China
    Beijing Hospital
Feb 3, 2023

rOutine Using afLibERcept: Strict vs relAxed retreatmeNT Regimen

Completed
  • Age Related Macular Degeneration
  • Bern, Switzerland
  • +1 more
Nov 28, 2022

Wet Macular Degeneration Trial in Prague (Aflibercept 40 MG/ML [Eylea], Brolucizumab-Dbll 120 MG/ML [Beovu], Ranibizumab 6 MG/ML

Withdrawn
  • Wet Macular Degeneration
  • Aflibercept 40 MG/ML [Eylea]
  • +2 more
  • Prague, Czechia
    Department of Ophthalmology, Faculty hospital Kralovske Vinohrad
Aug 7, 2022

Intravitreal Aflibercept in Diabetic Macular Edema and/or

Completed
  • Macular Edema
  • Aflibercept (Eylea, BAY86-5321)
  • Multiple Locations, China
  • +10 more
Nov 10, 2022

Wet Age-related Macular Degeneration Trial (SCB-420, Aflibercept)

Withdrawn
  • Wet Age-related Macular Degeneration
  • (no location specified)
Apr 12, 2022

s in Wet Age-related Macular Degeneration Which Have Never

Active, not recruiting
  • Wet Age-related Macular Degeneration
  • Aflibercept (Eylea, BAY86-5321)
  • Multiple Locations, Argentina
  • +16 more
Jan 16, 2023

Wet Age-related Macular Degeneration Trial in Beijing (Aflibercept)

Completed
  • Wet Age-related Macular Degeneration
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Apr 19, 2022

Wet Age-related Macular Degeneration Trial in Boston, Worcester (Intravitreal anti-VEGF, Intravitreal AAVCAGsCD59, Oral

Completed
  • Wet Age-related Macular Degeneration
  • Intravitreal anti-VEGF
  • +2 more
  • Boston, Massachusetts
  • +1 more
May 24, 2022